Skip Ribbon Commands
Skip to main content
CIBMTR

Retired Forms Manuals

Sharing knowledge. Sharing Hope.
Skip Navigation LinksHome   |   Data Management   |   Training and Reference   |   Manuals   |   Retired Forms Manuals
  • Print
  • Share

Retired Forms Manuals

For reference purposes, CIBMTR provides online access to manuals for retired CIBMTR and NMDP/Be The Match forms, Appendices and General Instruction documents.  See the sections below for all retired content.   

Retired Forms Manuals​
Form Number​ Form Name Form Version ​Retired Date
​2000 Baseline Form Instructions (PDF) ​4.0 ​March 2015
2000​ Baseline Form Instructions (PDF)​ ​3.0 ​October 2013
​2004 Infectious Disease Markers Form Instructions (PDF) ​4.0 March 2015
2004​ Infectious Disease Markers Form Instructions (PDF)  ​3.0 ​October 2013
​2005 Confirmation of HLA Typing Form Instructions (PDF) ​5.0 March 2015
2005​ Confirmation of HLA Typing Form Instructions (PDF) ​4.0 ​October 2013
​2006 Infusion Form Instructions (PDF) ​4.0 ​March 2015
2006​ Infusion Form Instructions (PDF) ​2.0 ​October 2013
2006​ Infusion Form (2006) Resources 1.0​ ​February 2010
​2010 Acute Myelogenous Leukemia (AML) Pre-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
2010​ Acute Myelogenous Leukemia (AML) Pre-HSCT Data Form Instructions (PDF) ​2.0 ​October 2013
​2011 Acute Lymphoblastic Leukemia (ALL) Pre-HCT Data Form Instructions (PDF) ​4.0 ​March 2015
2013 Chronic Lymphocytic Leukemia (CLL) Pre-HCT Data Form Instructions (PDF) ​2.0 March 2015
​2014 Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Pre-HCT Data Form Instructions (PDF) ​3.0 March 2015
​2015 Juvenile Myelomonocytic Leukemia (JMML) Pre-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
​2016 ​Multiple Myeloma / Plasma Cell Disorders (PCD) Pre-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
2016​ Multiple Myeloma / Plasma Cell Leukemia Pre-HSCT Data Form Instructions (PDF) ​2.0 ​October 2013
​2018 Hodgkin and Non-Hodgkin Lymphoma (LYM) Pre-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
2018​ Hodgkin and Non-Hodgkin Lymphoma Pre-HSCT Data Form Instructions (PDF) ​2.1 ​October 2013
​2019 Waldenstrom's Macroglobulinemia / Lymphoplasmacytic Lymphoma (MAC) Pre-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
​2028 Aplastic Anemia Pre-HCT Data Form Instructions (PDF) ​2.0 ​March 2015
​2034 ​X-Linked Lymphoproliferative Syndrome (XLP) Pre-HCT Data Form Instructions ​3.0 ​March 2015
​2039 Hemophagocytic Lymphohistiocytosis (HLH) Pre-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
​2100 100 Days Post-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
​2110 Acute Myelogenous Leukemia (AML) Post-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
2110​ Acute Myelogenous Leukemia (AML) Post-HSCT Data Form Instructions (PDF) ​2.0 ​October 2013
​2111 Acute Lymphocytic Leukemia (ALL) Post-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
​2113 Chronic Lymphocytic Leukemia (CLL) Post-HCT Data Form Instructions (PDF) ​2.0 ​March 2015
​2114 Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
​2115 ​Juvenile Myelomonocytic Leukemia (JMML) Post-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
​2116 ​Multiple Myeloma / Plasma Cell Disorders (PCD) Post-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
2116​ Multiple Myeloma / Plasma Cell Leukemia Post-HSCT Data Form Instructions (PDF) ​2.0 ​October 2013
​2118 ​Hodgkin and Non-Hodgkin Lymphoma (LYM) Post-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
2118​ Hodgkin and Non-Hodgkin Lymphoma Post-HSCT Data Form Instructions (PDF) ​2.0 ​October 2013
​2119 Waldenstrom's Macroglobulinemia / Lymphoplasmacytic Lymphoma (MAC) Post-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
​2128 ​Aplastic Anemia Post-HCT Data Form Instructions (PDF) ​2.0 ​March 2015
​2134 ​X-Linked Lymphoproliferative Syndrome (XLP) Post-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
​2139 ​Hemophagocytic Lymphohistiocytosis (HLH) Post-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
​2200 ​Six Months to Two Years Post-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
​2300 Greater Than Two Years Post-HCT Data Form Instructions (PDF) ​3.0 ​March 2015
​2400 ​Pre-TED Form Instructions (PDF) ​4.0 ​March 2015
2400​ Pre-TED Form Instructions (PDF) ​3.0 ​October 2013
​2450 Post-TED Form Instructions (PDF) ​3.0 ​March 2015
​2800 Log of Appended Documents Form Instructions (PDF) ​2.0 ​March 2015
​General Instructions Section 11 Log of Appended Documents ​N/A ​August 2014
​2804 CIBMTR Recipient ID Assignment Form Instructions (PDF) ​4.0 ​March 2015
​2900 ​Recipient Death Data Form Instructions (PDF) ​March 2015
N/A​ Supplemental Report Form Manuals N/A​ ​September 2013
N/A​ TED Manual (PDF) N/A​ ​January 2008
N/A NMDP Forms Instruction Manual (PDF) N/A​ ​December 2007
​N/A CIBMTR Data Management Manual (PDF) ​N/A ​December 2007
​N/A CIBMT Registration Instruction Manual (PDF) ​N/A ​December 2007

  

Appendices
Table of Contents (PDF) Appendices Table of Contents
Appendix A (PDF) Abbreviations and Definitions
Appendix B (PDF) Glossary of Terms
Appendix C (PDF) CIBMTR Data Collection Forms
Appendix D (PDF) Unique ID Assignment Form (CRID), Form 2804
Appendix E (PDF) Public Health Authority (PHA) Status
Appendix F (PDF) Validation Ranges
Appendix G (PDF) Continuous Process Improvement (CPI) and Procedures for Non-Compliance
Appendix H (PDF) Summary of CIBMTR On-Site Data Audit Program
Appendix I (PDF) Ethnicity and Race
Appendix J (PDF) CIBMTR Contact Information
Appendix K (PDF) Key Fields
Appendix L (PDF) Karnofsky/Lansky Performance Status
Appendix M (PDF) The Hematopoietic Cell Transplant-Co-morbidity Index (HCT-CI)
Appendix N (PDF) Response Evaluation Criteria in Solid Tumors (RECIST)
Appendix O (PDF) How to Distinguish Infusion Types
Appendix P (PDF) Definition of Product
Appendix Q (PDF) United States Abbreviations
​Appendix R (PDF) ​Cytogenetic Abbreviations and Terminology
Appendix S (PDF)
​Multiple Donor Chimerism
Appendix T (PDF) ​Pre-HCT Treatment for Lymphoma
Appendix U (PDF) Helpful Hints for Reporting Co-Existing Diseases​
Appendix V (PDF) Multiple Myeloma - Defining What Baseline to Use When Determining the Best Response to HSCT
Appendix W (DOC) Tracking Disease Status for Multiple Myeloma
Appendix Y (PDF) ​Critical Fields
Appendix Z (PDF) ​Primary Disease and Disease Inserts Due

 

 

General Instructions
Table of Contents (PDF) General Instructions
Section 1 (PDF) Introduction
Section 2 (PDF) Stem Cell Therapeutic Outcomes Database (SCTOD)
Section 3 (PDF) Center Type and Data Collection Forms
Section 4 (PDF) Autologous Hematopoietic Stem Cell Transplant
Section 5 (PDF) EBMT Centers
Section 6 (PDF) Protocols and Consent Forms
Section 7 (PDF) Unique ID Assignment (CRID) & Protected Health Information, Form 2804
Section 8 (PDF) FormsNet
Section 9 (PDF) Forms Due Report
Section 10 (PDF) CIBMTR Campus & CRC Assignment
Section 12 (PDF) Declaring Recipients Lost to Follow-Up
Section 13 (PDF) Recipient Transfers
Section 14 (PDF) General Guidelines for Completing Forms
Section 15 (PDF) How to Avoid Errors
Section 16 (PDF) Reimbursement for Forms Completion
Section 17 (PDF) Continuous Process Improvement (CPI)
Section 18 (PDF) On-Site Data Audits
Section 19 (PDF) Helpful Web sites and CIBMTR Contact Information

 

 

To view PDF documents you will need Adobe Reader.
Get Adobe Reader


Last Updated: 1/3/2017 2:21 PM
CIBMTR